David Bleakman, PhD
David is an internationally recognized neuroscientist and expert in drug discovery and development who most recently held the position as Chief Scientific Officer of Redpin Therapeutics, a chemogenetics biotechnology company based in New York City, NY. Previously,...
Mark Varney, Ph.D.
Dr. Varney received his Ph.D. and post-doctoral training in Pharmacology from Oxford University, UK. He is Chief Scientific Officer of PsychoGenics, a preclinical CNS service company engaged in psychiatric drug discovery. Dr. Varney has more than 30 years of...
Dani Brunner, Ph.D.
Dr. Brunner received her PhD at Cambridge University (UK), and post-doctoral training at Columbia University (USA). She joined PsychoGenics in 1999 where she developed preclinical tests for cognition, neurodegeneration, autism, between others. She conceived the...
Recent Comments